In his latest commentary, Dr. Shybut argues that current evidence doesn’t support routine use of PRP to augment ACL reconstruction, while still calling for continued innovation in biologic enhancements.

Click to view Dr. Shybut’s Editorial Commentary: https://www.arthroscopyjournal.org/article/S0749-8063(25)00601-2/fulltext